Insider Selling in the Wake of an AI Partnership
On February 25, 2026, Voskanian Shaunt, Chief Revenue Officer of Figma, sold 8,554 shares of the company’s Class A common stock at a price of $30.00 per share. The transaction was executed under a Rule 10b‑5‑1 trading plan. At the time of the sale, the share price hovered around $29.39, and the transaction reduced Shaunt’s holdings to 1,580,181 shares. While the proceeds from this single trade are modest relative to his overall stake, the sale follows a series of larger disposals earlier in 2026 and late 2025, indicating a pattern of periodic divestiture rather than a one‑off event.
Investor Sentiment Reflected in Insider Activity
The broader pattern of insider trading paints a mixed picture. Several executives—including the Chief Technology Officer and a number of venture partners—have been selling heavily in the last few months, suggesting that they view the current share price as reflecting fair value or that they require liquidity. The timing of these sales is notable: they occurred a few days after the announcement of a high‑profile partnership between Figma and OpenAI, which spurred a 21.5 % weekly surge in the stock and attracted media attention exceeding 86 %. Investors are still assessing whether the AI integration will translate into sustainable revenue growth. This uncertainty is compounded by the company’s negative price‑earnings ratio of –7.03, which signals that earnings per share remain below zero.
The recent sale therefore may signal a cautious stance from insiders who are hedging against potential volatility that could arise from a transformative but unproven technology shift.
Implications for Figma’s Future
If insiders continue to sell, the cumulative effect could undermine confidence among price‑sensitive investors and pressure the share price further downward. Conversely, a sustained trend of buying by other executives or institutional holders—such as Ark Invest’s recent purchase—may offset the sell pressure. For Figma, the key question is whether the OpenAI partnership will generate a significant revenue lift and justify a higher valuation. The company’s market capitalization of $12.9 billion and a recent 0.75 % monthly gain suggest cautious optimism, but the negative earnings and steep yearly decline of –74.55 % underscore the risk of overvaluation.
Profile of Voskanian Shaunt
Shaunt’s trading history reveals a disciplined approach to liquidity management. Over the past 12 months, he has executed multiple sales ranging from 2,188 shares at $25.24 to 26,741 shares at $48.17, consistently reducing his stake while maintaining a sizable holding above 1.5 million shares. All of his trades have been executed via a 10b‑5‑1 plan, indicating a pre‑arranged schedule rather than reactionary selling. This pattern suggests that he views the stock as a long‑term investment while periodically rebalancing his portfolio. The recent sale at $30.00 aligns with this trend, likely reflecting a need to free up capital for other opportunities or to diversify holdings.
Takeaway for Investors
Insider selling, especially when tied to a major partnership announcement, can be a double‑edged sword. For cautious investors, Shaunt’s sale may reinforce concerns about the immediate financial impact of the OpenAI tie‑in. However, the continued presence of sizeable holdings and positive media buzz indicate that the company’s strategic direction still retains appeal. Monitoring subsequent insider activity—particularly any buying by other executives or institutional stakeholders—will be crucial for assessing whether Figma’s stock will consolidate gains or retreat under the weight of sell pressure.
| Date | Owner | Transaction Type | Shares | Price per Share | Security |
|---|---|---|---|---|---|
| 2026‑02‑25 | Voskanian Shaunt (Chief Revenue Officer) | Sell | 8,554 | 30.00 | Class A Common Stock |
| 2026‑02‑25 | Rasmussen Kris (Chief Technology Officer) | Sell | 51,359 | 30.00 | Class A Common Stock |
| 2026‑02‑25 | Kleiner Perkins Caufield & Byers XVII, LLC | Sell | 4,763,981 | N/A | Class A Common Stock |
| 2026‑02‑25 | Kleiner Perkins Caufield & Byers XVII, LLC | Sell | 155,962 | N/A | Class A Common Stock |
| 2026‑02‑25 | Kleiner Perkins Caufield & Byers XVII, LLC | Buy | 1,190,996 | N/A | Class A Common Stock |
| 2026‑02‑25 | Kleiner Perkins Caufield & Byers XVII, LLC | Sell | 1,188,289 | N/A | Class A Common Stock |




